UK markets close in 4 hours 27 minutes

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.38+0.04 (+0.43%)
At close: 04:00PM EDT
9.44 +0.06 (+0.64%)
Pre-market: 07:00AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate-0.41-0.41-1.67-1.87
Low estimate-0.46-0.52-2-3.4
High estimate-0.37-0.36-1.49-1.18
Year ago EPS-0.38-0.43-1.58-1.67
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate13.75M13.93M58.91M90.45M
Low estimate11M11M45M43.92M
High estimate20.8M20.8M83.3M254.9M
Year ago sales11.02M10.53M44.58M58.91M
Sales growth (year/est)24.80%32.30%32.20%53.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.37-0.38-0.45-0.42
Actual EPS-0.38-0.43-0.42-0.39
Difference-0.01-0.050.030.03
Surprise %-2.70%-13.20%6.70%7.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.41-0.41-1.67-1.87
7 days ago-0.41-0.41-1.67-1.87
30 days ago-0.41-0.41-1.67-1.87
60 days ago-0.42-0.43-1.72-1.86
90 days ago-0.42-0.43-1.72-1.86
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRXRXIndustrySector(s)S&P 500
Current qtr.-7.90%N/AN/AN/A
Next qtr.4.70%N/AN/AN/A
Current year-5.70%N/AN/AN/A
Next year-12.00%N/AN/AN/A
Next 5 years (per annum)12.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A